Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Epidemiology

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0895-4356(99)00203-6PMID 10941943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer

  2004cited by this paper
• Prophylactic treatment for superficial bladder cancer following transurethral resection

  2004cited by this paper
• A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer-intravesical thio-TEPA versus oral UFT

  2004cited by this paper
• Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results

  2004cited by this paper
• The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.

  1996cited by this paper
• A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.

  1996cited by this paper
• The Handbook of Research Synthesis

  1995cited by this paper
• Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.

  1995cited by this paper
• Cancer statistics, 1995

  1995cited by this paper
• Adjuvant intravesical mitoxantrone after transurethral resection of primary superficial transitional cell carcinoma of the bladder. A prospective randomised study.

  1995cited by this paper
• Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy

  1994cited by this paper
• Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG).

  1994cited by this paper
• Meta-analytic stimulus for changes in clinical trials

  1993cited by this paper
• An overview of intravesical therapy for superficial bladder tumors.

  1987cited by this paper
• Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer

  1987cited by this paper
• Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer

  1987cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper

• Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer—From Early Detection to Prognosis

  2024cites this paper
• Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

  2022cites this paper
• Impact of Urinary pH on the Efficacy of a Postoperative Single Instillation of Mitomycin-C.

  2022cites this paper
• Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial

  2022cites this paper
• NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.

  2022cites this paper
• A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer

  2022cites this paper
• CUA GUIDELINE Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Full-text

  2021cites this paper
• Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.

  2021cites this paper
• CUAJ – CUA Guideline Bhindi et al Guideline: NMIBC management

  2021cites this paper
• Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer.

  2021cites this paper
• A comparative Study between single session versus Six Sessions Mitomycin C instillation in Patients with Low Risk Non-Muscle Invasive Bladder Cancer

  2021cites this paper
• Bladder Cancer

  2020cites this paper
• Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Clinical recommendations for diagnosis, treatment and monitoring of patients with bladder cancer

  2019cites this paper
• EAU Guidelines pro léčbu uroteliálního karcinomu močového měchýře , který neinvaduje svalovinu – aktualizovaná verze z roku 2011

  2019cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY

  2019cites this paper
• Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel

  2018cites this paper
• The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer.

  2018cites this paper
• Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy

  2018cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Early-Invasive Urothelial Bladder Carcinoma and Instillation Treatment of Non-muscle-Invasive Bladder Cancer

  2018cites this paper
• Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer

  2018cites this paper
• Intravesical device-assisted therapies for non-muscle-invasive bladder cancer

  2018cites this paper
• Management of Non-muscle-Invasive and Muscle-Invasive Bladder Cancers

  2017cites this paper
• Tackling non-muscle invasive bladder cancer in the clinic

  2017cites this paper
• Guideline of guidelines: non‐muscle‐invasive bladder cancer

  2017cites this paper
• A COMPARATIVE STUDY BETWEEN SINGLE SESSION VERSUS SIX SESSIONS MITOMYCIN C INSTILLATION IN PATIENTS WITH LOW RISK NON-MUSCLE INVASIVE BLADDER CANCER

  2017cites this paper
• Mitomycin C: New Strategies to Improve Efficacy of a Well-Known Therapy

  2016cites this paper
• Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis

  2016cites this paper
• Bladder cancer

  2016cites this paper
• Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

  2016cites this paper
• Endoscopic Treatment of Bladder Tumors

  2016cites this paper
• Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer

  2015cites this paper
• Intravesical therapy for bladder cancer

  2015cites this paper
• CUA guidelines on the management of non-muscle invasive bladder cancer.

  2015cites this paper
• Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study.

  2015cites this paper
• Clinical Scenario: Rapidly Growing, High Volume, Low-Grade Ta Tumor

  2015cites this paper
• Intravesical Therapy for Bladder Cancer

  2015cites this paper
• 6. Intravesical chemotherapy

  2015cites this paper
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

  2014cites this paper
• Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy

  2014cites this paper
• Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS)

  2014cites this paper
• Guideline for the Management of Nonmuscle Invasive Bladder Cancer : ( Stages Ta , T 1 , and Tis ) : 2007 Update Bladder Cancer

  2014cites this paper
• Nephron-sparing Management of Upper Tract Urothelial Carcinoma.

  2014cites this paper
• Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato.

  2013cites this paper
• Bladder cancer.

  2013cites this paper
• Endovesical Treatment as an Alternative to BCG for Intermediate or High-Risk NMI Bladder Cancer

  2013cites this paper
• Perioperative chemotherapy: when to use it, what to use, and why.

  2013cites this paper
• Safety Notice for the Use of Drugs for Intravesical Instillations and Cost Analysis

  2013cites this paper
• Update on the management of non-muscle invasive bladder cancer.

  2013cites this paper
• Guidelines on Non-muscle invasive Bladder Cancer

  2013cites this paper
• Current strategies in the treatment of non-muscle-invasive bladder

  2012cites this paper
• Strengths and Weaknesses of Immunotherapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of 12 Randomized Controlled Trials

  2012cites this paper
• Current strategies in the treatment of non-muscle-invasive bladder cancer

  2012cites this paper
• Impact of surgery and epirubicin intravesical chemotherapy on peripheral blood dendritic cell subsets in patients with superficial urothelial carcinoma of the bladder.

  2012cites this paper
• Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011: Actualización de 2011

  2012cites this paper
• [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

  2012cites this paper
• Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients

  2012cites this paper
• Anforderungen an eine klinische Datenbank beim Harnblasenkarzinom: Datenbanktheorie und Auswahl der Parameter

  2011cites this paper
• Chemotherapeutic Agents for Urologic Oncology

  2011cites this paper
• Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer

  2011influential citation
• Lokální chemoprofylaxe Mitomycinem C u středně a vysokorizikových neinvazivních nádorů močového měchýře

  2011cites this paper
• Bacillus Calmette–Guérin treatment of non‐muscle invasive bladder cancer

  2011cites this paper
• Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.

  2011cites this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

  2011cites this paper
• A 1‐year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non‐muscle‐invasive bladder cancer

  2010cites this paper
• Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

  2010cites this paper
• Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.

  2010cites this paper
• instillation therapy for low-grade superficial bladder cancer : a case control study

  2010cites this paper
• Investigational therapies for non-muscle invasive bladder cancer

  2010cites this paper
• Update on intravesical agents for non-muscle-invasive bladder cancer.

  2010cites this paper
• Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

  2009influential citation
• Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai

  2009cites this paper
• Intra-Arterial Chemotherapy is Reliable in Preventing High-Risk Superficial Bladder Cancer from Recurrence and Progression

  2009cites this paper
• Guía clínica del carcinoma urotelial no músculo invasivo de la Asociación Europea de Urología

  2009cites this paper
• Clinical outcome of tumor recurrence for Ta, T1 non‐muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999–2001 report from the Japanese Urological Association

  2009cites this paper
• [EAU guidelines on non-muscle-carcinoma of the bladder].

  2009cites this paper
• – Bladder Cancer EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

  2008cites this paper
• Gene polymorphisms in bladder cancer.

  2008cites this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

  2008cites this paper
• Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer: Evidence and Opinion

  2008cites this paper
• Validierung des NMP22®BladderChek als Marker für das Harnblasenkarzinom an der Photodynamischen Diagnostik (PDD)

  2008cites this paper
• The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials.

  2008cites this paper
• Diagnostic and Prognostic Factors in Non-Muscle-Invasive Bladder Cancer and Their Influence on Treatment and Outcomes ☆

  2008cites this paper
• Regional Therapy of Bladder Tumors

  2007cites this paper
• Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.

  2007cites this paper
• Superficial bladder cancer: part 2. Management.

  2007cites this paper
• Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

  2006cites this paper
• Ureter, Bladder, Penis, and Urethra

  2006cites this paper
• Guidelines on TaT 1 ( Non-muscle invasive ) Bladder Cancer

  2006cites this paper
• Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer

  2006cites this paper
• Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.

  2006cites this paper
• Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.

  2006cites this paper
• Superficial Bladder Cancer Therapy: A Review

  2005cites this paper
• New agents in intravesical chemotherapy of superficial bladder cancer

  2005cites this paper
• Mecanismos del ciclo celular y la apoptosis implicados en las resistencias a los fármacos de uso intravesical en el cáncer superficial de vejiga

  2005cites this paper
• Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer.

  2005cites this paper
• Bladder cancer. Clinical practice guidelines in oncology.

  2005cites this paper
• [Cell cycle and apoptosis mechanisms implicated in intravesical chemotherapy resistances in superficial bladder cancer].

  2005cites this paper
• Aktuelle Aspekte in der adjuvanten und neoadjuvanten Therapie des Harnblasenkarzinoms

  2004cites this paper